Related Experiment Video
Updated: Nov 21, 2025

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
Symptomatic atrioventricular block during biventricular pacing: Facing a double trouble
Debabrata Bera1, Suchit Majumder2, Anup Khetan3
1Division of Electrophysiology, Department of Cardiology, RTIICS, Kolkata, India.
Abstract:
Far-field R wave (FFRW) oversensing in atrial channel is known to cause inappropriate automatic mode switch. We describe a case of 63-year-old lady with dual-chamber permanent pacemaker implanted 2 years back for symptomatic infra-hisian complete heart block and normal biventricular function. After 6 months, she underwent upgradation to cardiac resynchronization therapy (CRT-P, Boston Scientific) for right ventricular pacing induced cardiomyopathy. Her LV function normalized after CRT. Later on, FFRW oversensing caused false triggering of an atrial tachycardia, which subsequently opened up an "atrial flutter response" window leading to symptomatic inadvertent atrioventricular block at frequent intervals. Common ways to troubleshoot FFRW oversensing are either by increasing post-ventricular atrial blanking or reducing atrial channel sensitivity. In her case, concomitant P wave under-sensing made the situation more challenging to manage.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10:17Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmias III: Characteristics of Dysrhythmias
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers